U.S. Other Utilities Stock News

EMCOR Group has recently attracted positive attention after highlighting strong financial strength, profitability, and growth metrics, supported by rising demand across key electrical and mechanical construction end markets and several 2025 acquisitions, including Miller Electric. The company’s raised 2025 revenue, operating margin, and EPS outlook, alongside high-quality analyst endorsement, underscores management’s confidence and its perceived competitive position within facilities...

Immunocore Holdings (NasdaqGS:IMCR) announced an overhaul of its R&D leadership following the planned departure of EVP of Research & Development, Dr. David Berman. Instead of appointing a direct successor, the company is expanding the responsibilities of internal leaders Dr. Mohammed Dar and Mark Moyer. The leadership changes are expected to reshape how Immunocore manages clinical development and regulatory activities. Immunocore Holdings enters this leadership transition with its shares...

CorMedix (NasdaqGM:CRMD) is hosting an analyst day focused on its late stage clinical programs. The event will feature updates on REZZAYO for fungal infection prophylaxis and DefenCath for catheter related bloodstream infection prevention. Management is expected to outline current program status and broader business direction for these key assets. For investors watching CorMedix, the focus is on how these late stage assets fit into the broader infection prevention space. REZZAYO and...

Madrigal Pharmaceuticals (MDGL) has recently drawn attention after a mixed pattern in its share performance, with a negative month return but a positive move over the past 3 months and a strong one year total return. See our latest analysis for Madrigal Pharmaceuticals. Recent trading has been choppy, with a 30 day share price return of a 16% decline and a year to date share price return of an 18% decline, yet the 1 year total shareholder return of 46% suggests longer term momentum has still...

If you are wondering whether Travere Therapeutics at around US$31.09 is offering fair value or an opportunity, you are not alone. This article is built to help you size that up clearly. The stock has had a mixed run, with a 5.6% gain over the last 7 days but an 18.6% decline over 30 days, while still sitting on a 52.0% return over 1 year and 43.1% over 3 years, compared with a 2.1% decline over 5 years. Recent coverage of Travere Therapeutics has focused on its position in the...

Duke Energy prepared for severe winter weather in the Carolinas and Florida with grid hardening work and customer safety outreach. The company activated response plans as storms moved through, leading to widespread outages across parts of its service territory. Crews were deployed for large scale restoration efforts, supported by advanced self healing grid technologies aimed at shortening outages. Duke Energy, trading as NYSE:DUK, sits at the center of a major power reliability story as...

TeraWulf (WULF) is drawing fresh investor attention after securing large financing for high performance computing and AI facilities, backed by long term HPC contracts and support from partners such as Google and Fluidstack. See our latest analysis for TeraWulf. The latest funding news comes after a sharp pullback, with a 1 day share price return of an 8.05% decline and a 7 day share price return of a 5.31% decline. However, the 30 day share price return of 16.36% and the very large 3 year...

If you are wondering whether General Dynamics shares still offer value after a strong run, this article walks through what the current price might be implying about the business. The stock last closed at US$351.09, with a 1 year return of 39.3% and a 5 year return of 146.4%, while the past week shows a 3.4% decline and the past month a 4.3% gain. These figures can change how investors think about both opportunity and risk. Recent news coverage has focused on General Dynamics as a major US...

Abercrombie & Fitch (ANF) is back in focus after being named the NFL's Official Fashion Partner for the upcoming Super Bowl, tying its stock story to high visibility events across sports and fashion. See our latest analysis for Abercrombie & Fitch. The Super Bowl tie up comes at a time when Abercrombie & Fitch’s share price of $97.63 sits below recent highs. A 90 day share price return of 34.57% contrasts with a 22.44% decline over 30 days and a three year total shareholder return of 224.68%,...

Agnico Eagle Mines (NYSE:AEM) has agreed to sell its remaining 55% stake in Gunnarn Mining AB, including the Barsele project, to Goldsky Resources. The company will retain a royalty interest on the project, aligning with its portfolio optimization approach. The transaction structure includes cash, equity in Goldsky Resources, and ongoing royalty exposure. Agnico Eagle Mines is a major gold producer, so any portfolio reshaping around projects like Barsele can matter for how its asset base...

If you are wondering whether Southwest Airlines is still fairly priced after its recent run, you are not alone. This article focuses squarely on what the current share price might be implying. The stock recently closed at US$47.52, with returns of 13.3% over 7 days, 15.0% over 30 days, 15.1% year to date, 58.1% over 1 year and 39.8% over 3 years, while the 5 year return stands at 2.0%. Recent headlines around Southwest Airlines have focused on its operational recovery and route capacity...

Dividend declaration and why it matters now Marathon Petroleum (MPC) has just declared a US$1.00 per share common stock dividend, payable on March 10, 2026 to shareholders of record at the close of business on February 18, 2026. See our latest analysis for Marathon Petroleum. At a share price of US$176.19, Marathon Petroleum has seen an 8.34% 1 month share price return and a 6.69% year to date share price return, while its 1 year total shareholder return of 23.60% and very large 5 year total...

USA Rare Earth (NasdaqGM:USAR) has secured a $1.3b U.S. federal loan, a $277m direct federal equity investment, and a $1.5b private placement. The funding package makes the U.S. government one of USAR's largest shareholders and supports a domestic mine to magnet supply chain. The transaction introduces milestone based funding and no price supports, setting different terms compared with some peers in critical minerals. For investors watching critical minerals, USA Rare Earth now sits at the...

Southern Copper Corporation recently reported fourth-quarter 2025 sales of US$3,869.8 million and net income of US$1,307.9 million, capping a year in which full-year sales reached US$13.42 billion and net income climbed to US$4.33 billion. Alongside these record results, management flagged a copper market deficit and lower near-term production due to declining ore grades in Peru, while still committing to substantial growth projects like the Tía María development. Next, we’ll examine how...

In late January 2026, Zebra Technologies highlighted that Sentinel’s automotive customers are using its Poka Yoke inspection solution, combining Zebra’s AltiZ Series High-Fidelity 3D Profile Sensor with Sentinel’s Vision Core AI software to cut defect rates and speed up machine commissioning. This collaboration underscores how Zebra’s vision and RFID technologies are being applied across both factory floors and NFL fields to deliver real-time, data-rich insights. We’ll now examine how this...

If you are wondering whether Genius Sports is offering fair value at its current price, you are not alone, as the stock has been attracting attention from investors who want to know what they are really paying for its growth story. The shares last closed at US$8.70, with returns of a 10% decline over 7 days, a 21.1% decline over 30 days, a 19.3% decline year to date and a 1.5% decline over 1 year, while the 3 year return sits at 59.3% and the 5 year return at a 58.1% decline. Recent news...

ARK Investment Management has significantly expanded its position in CRISPR Therapeutics (NasdaqGM:CRSP), purchasing a large block of shares. The move highlights ARK's confidence in CRISPR Therapeutics' role in gene editing and its clinical pipeline. The news coincides with continued work on gene editing therapies targeting beta thalassemia, sickle cell disease, cardiovascular conditions, and type 1 diabetes. CRISPR Therapeutics' share price recently stood at $49.96, with the stock showing...

CleanSpark (CLSK) has drawn fresh attention after recent trading moves left the bitcoin miner with a year to date return close to 3%, despite a decline of about 33% over the past 3 months. See our latest analysis for CleanSpark. The recent pullback, including a 1-day share price return of a 5.96% decline and a 7-day share price return of a 13.64% decline from the latest close at $11.84, comes after a 30-day share price return of 17.00% and a 1-year total shareholder return of 13.41%. Recent...

In late January 2026, Gartner, Inc. expanded its Board of Directors to 13 members by appointing MIT AI and robotics leader Professor Daniela Rus and veteran investment executive Edward Bousa, with 12 directors now classified as independent. The combination of Rus’s deep artificial intelligence expertise and Bousa’s long-tenured capital markets experience underscores Gartner’s emphasis on technology leadership and governance depth at the board level. We’ll now examine how this infusion of AI...

East West Bancorp (EWBC) just reported stronger than expected fourth quarter results and announced a 33% increase in its quarterly dividend to $0.80 per share, a combination that sharpened the market’s focus on the stock. See our latest analysis for East West Bancorp. The latest set of results and the higher dividend come after a strong run for the stock, with a 90 day share price return of 12.64% and a 1 year total shareholder return of 13.93%. The 5 year total shareholder return of 100.36%...

If you are wondering whether Cirrus Logic shares still offer value at current levels, this article walks through what the numbers are really saying about the stock. The share price last closed at US$130.34, with returns of 2.4% over 7 days, 10.0% over 30 days, 8.9% year to date, 29.8% over 1 year and 52.7% over 5 years, which may have caught the attention of investors who follow price trends closely. Recent coverage around Cirrus Logic has focused on its role in the semiconductor space and...

Denali Therapeutics (DNLI) is back in focus after announcing it will present clinical and preclinical data from its Enzyme Transport Vehicle programs at the 22nd Annual WORLDSymposium in early February. See our latest analysis for Denali Therapeutics. The upcoming WORLDSymposium presentations and the FDA Priority Review have arrived after a strong run in the 1 month share price, with a 30 day share price return of 31.68% and a year to date share price return of 33.62%. However, the 1 year...

If you have ever wondered whether American Express shares are still priced reasonably after their long run, this article will walk you through what the current market price might be implying. The stock recently closed at US$352.17, with returns of 12.1% over 1 year and very large gains over 5 years. It has also shown a 2.6% decline over 7 days and a 5.5% decline over 30 days, and year to date it is down 5.5%. Recent news flow around American Express has largely centered on its role as a...

Why T1 Energy is back on investors’ radar T1 Energy (TE) has drawn fresh attention after recent market optimism around power demand linked to AI and data centers, along with its planned solar cell manufacturing facility in Texas. See our latest analysis for T1 Energy. That story has been reflected in the numbers, with T1 Energy’s 90-day share price return of 123.92% and 1-year total shareholder return of 343.09% pointing to strong recent momentum despite weaker multi year total shareholder...